CY1121445T1 - HYDROXYALYL STARCH IN COMBINATION WITH CYSTROSTATICS FOR THE TREATMENT OF CANCER THROUGH REDUCING VOLUME GROWTH RATE - Google Patents
HYDROXYALYL STARCH IN COMBINATION WITH CYSTROSTATICS FOR THE TREATMENT OF CANCER THROUGH REDUCING VOLUME GROWTH RATEInfo
- Publication number
- CY1121445T1 CY1121445T1 CY20181101141T CY181101141T CY1121445T1 CY 1121445 T1 CY1121445 T1 CY 1121445T1 CY 20181101141 T CY20181101141 T CY 20181101141T CY 181101141 T CY181101141 T CY 181101141T CY 1121445 T1 CY1121445 T1 CY 1121445T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cancer
- treatment
- growth rate
- starch
- hydroxyalyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με υδροξυαλκυλο άμυλο ή φαρμακευτικό παρασκεύασμα αυτού για την αγωγή καρκίνου, όγκου ή παθήσεων συναφών με όγκους, ειδικά μέσω αποτελεσματικής μείωσης του ρυθμού αύξησης όγκου και αναστολής αύξησης όγκου και όπου το υδροξυαλκυλο άμυλο έχει μέσο μοριακό βάρος (MB) πάνω από 20 και κάτω από 1300 kDa και γραμμομοριακή υποκατάσταση (MS) στο εύρος από 0,1 έως 1,5, όπου η αλκυλίωση είναι δυνατόν να είναι αιθυλίωση, προπυλίωση ή βουτυλίωση ή μείξεις αυτών• και όπου το αλκύλιο είναι δυνατόν σε περαιτέρω επίπεδο να είναι υποκατεστημένο.The present invention relates to hydroxyalkyl starch or a medicament thereof for the treatment of cancer, tumor or tumor-related diseases, in particular by effectively reducing tumor growth rate and tumor growth inhibition and wherein the hydroxyalkyl starch has an average molecular weight of more than 20 and below 1300 kDa and molar substitution (MS) in the range of 0.1 to 1.5, wherein the alkylation may be ethylation, propylation or butylation or mixtures thereof; and wherein the alkyl may be further substituted .
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261592017P | 2012-01-30 | 2012-01-30 | |
| EP12153068 | 2012-01-30 | ||
| PCT/EP2013/000276 WO2013113496A1 (en) | 2012-01-30 | 2013-01-30 | Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates |
| EP13714546.2A EP2809329B1 (en) | 2012-01-30 | 2013-01-30 | Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121445T1 true CY1121445T1 (en) | 2020-05-29 |
Family
ID=65474822
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181101141T CY1121445T1 (en) | 2012-01-30 | 2018-11-01 | HYDROXYALYL STARCH IN COMBINATION WITH CYSTROSTATICS FOR THE TREATMENT OF CANCER THROUGH REDUCING VOLUME GROWTH RATE |
| CY20181101142T CY1121443T1 (en) | 2012-01-30 | 2018-11-01 | HYDROXYCYL STARCH FOR THE TREATMENT OF CANCER THROUGH REDUCING VOLUME GROWTH RATE |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181101142T CY1121443T1 (en) | 2012-01-30 | 2018-11-01 | HYDROXYCYL STARCH FOR THE TREATMENT OF CANCER THROUGH REDUCING VOLUME GROWTH RATE |
Country Status (4)
| Country | Link |
|---|---|
| CY (2) | CY1121445T1 (en) |
| HR (1) | HRP20181814T1 (en) |
| HU (2) | HUE041356T2 (en) |
| PT (2) | PT2809329T (en) |
-
2013
- 2013-01-30 PT PT13714546T patent/PT2809329T/en unknown
- 2013-01-30 HU HUE13701646A patent/HUE041356T2/en unknown
- 2013-01-30 HU HUE13714546A patent/HUE040080T2/en unknown
- 2013-01-30 PT PT13701646T patent/PT2809327T/en unknown
-
2018
- 2018-10-30 HR HRP20181814TT patent/HRP20181814T1/en unknown
- 2018-11-01 CY CY20181101141T patent/CY1121445T1/en unknown
- 2018-11-01 CY CY20181101142T patent/CY1121443T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE041356T2 (en) | 2019-05-28 |
| HUE040080T2 (en) | 2019-02-28 |
| PT2809329T (en) | 2018-11-16 |
| HRP20181814T1 (en) | 2019-03-22 |
| PT2809327T (en) | 2018-11-16 |
| CY1121443T1 (en) | 2020-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122393T1 (en) | PYRROLOPYRROLE COMPOUNDS AS ACTIVATORS OF PYROSTAPHYL KINASE (PKR) | |
| CY1121792T1 (en) | HETEROCYCLIC COMPOUND | |
| CY1124810T1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | |
| CY1118681T1 (en) | NEPRILYSIN Suspensions | |
| CY1116192T1 (en) | PYRROLOVENZODIAZEPINES AND THEIR CONNECTIONS | |
| CY1115585T1 (en) | Crystalline Forms of 5-Amino-2,3-Dihydrophthalazine-1,4-Dione Sodium Salt, Which Contain Pharmaceutical Forms | |
| CL2017002786A1 (en) | Cross reference to related requests | |
| CY1118468T1 (en) | CYCLOTIC URINE, THIOURIA, GUANIDINE AND KIANOGOVANIDINE COMPOUNDS USEFUL FOR PREVENTION OF PAIN | |
| CY1120736T1 (en) | COMPOSITIONS AND METHODS OF SUSPENSION MASP-1, MASP-2 Ή / and MASP-3 FOR TREATMENT OF PARASHOXIC NIGHT BLOOD | |
| CY1118899T1 (en) | CLOTHING UNITS, EXTRACTS, AND USES AND METHODS THEREOF | |
| CY1123988T1 (en) | PYRIDINE COMPOUND | |
| CY1118725T1 (en) | STABLE IRON-OLIGOSAKHARITE UNION | |
| MD4684B1 (en) | Imidazopyrazine-based formulations as SYK inhibitors | |
| MY182386A (en) | Pyrimidine-2,4-diamine derivatives for treatment of cancer | |
| NI201400109A (en) | CANCER TREATMENT WITH TOR KINASE INHIBITORS | |
| EA201291194A1 (en) | INDONESIA | |
| BR112017008995A2 (en) | carbohydrate cationic polymers for tissue treatment | |
| NZ723971A (en) | Methods and compositions for treating ewings sarcoma family of tumors | |
| PH12015502611A1 (en) | Heterocyclic compounds as hedgehog signaling pathway inhibitors | |
| CY1118318T1 (en) | US HOLDER REGULATORS X | |
| CY1120573T1 (en) | PYRIDAZINE PRODUCTS FOR USE IN PREVENTION OR CLASSICAL DISORDER TREATMENT | |
| CY1122439T1 (en) | CYCLOALKYL-LINKED BI-HETEROCYCLE DERIVATIVES | |
| SA518400493B1 (en) | Pegylated Carfilzomib Compounds | |
| EA201491227A1 (en) | NEW MORFOLINIL DERIVATIVES SUITABLE FOR USING AS MOGAT-2 INHIBITORS | |
| MX2018008507A (en) | Inhibiting ataxia telangiectasia and rad3-related protein (atr). |